title: [Mucoactive therapy in pulmonological practice: current aspects].
abstract: The paper describes the causes of mucostasis and the mechanisms of its development. It presents classifications of mucolytic drugs. A group of combination mucolytic drugs is identified by indicating the standard of their design and usage. The characteristics of the drugs including the combination agent ascoril are described in detail and information on the successful results of its use is given.
authors.forename: N M
authors.initials: NM
authors.lastname: Shmeleva
authors.forename: E I
authors.initials: EI
authors.lastname: Shmelev
mesh_terms: D001982:Bronchial Diseases / Q000188:drug therapy* / Q000473:pathology; D004338:Drug Combinations; D006801:Humans; D052016:Mucositis / Q000188:drug therapy / Q000473:pathology; D015272:Pulmonary Medicine / Q000379:methods*; D020545:Respiratory Mucosa / Q000187:drug effects* / Q000473:pathology*
chemical_list: D004338:Drug Combinations